4//SEC Filing
Theagene Jean-Manasse 4
Accession 0001127602-24-024933
CIK 0001878313other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:45 PM ET
Size
5.2 KB
Accession
0001127602-24-024933
Insider Transaction Report
Form 4
Theagene Jean-Manasse
Director
Transactions
- Award
Stock Options
2024-09-30+7,232→ 7,232 totalExercise: $2.81From: 2024-09-30Exp: 2034-09-30→ Common Stock (7,232 underlying)
Footnotes (1)
- [F1]The stock options, granted on September 30, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of thate date.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001969857
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 4:45 PM ET
- Size
- 5.2 KB